Onyx Biotec Limited

NSE: ONYX
Onyx Biotec Limited - chemicals in Solan, Himachal Pradesh, India. FY 2026 financials & compliance.
CIN L24230HP2005PLC028403 Incorporated 13 May 2005 ROC Himachal Pradesh HQ Solan, Himachal Pradesh, India
Active Listed - NSE: ONYX Public Limited Company chemicals MSME · Small
Data last updated
Market Cap
₹61.65 Cr
ONYX-SM · NSE
Share Price
₹35.70
+5.00% today
Revenue
₹69.47 Cr
FY 2025-26 · +12.1% YoY
EBITDA
₹3.40 Cr
Margin 4.9%
Net Profit
−₹0.21 Cr
FY 2025-26 · -105.0% YoY
Authorised capital
₹20 Cr
Registered with MCA
Paid-up capital
₹18.13 Cr
Issued & subscribed
Open charges
₹29.94 Cr
Satisfied ₹65.28 Cr

About Onyx Biotec Limited

Data last updated:

Onyx Biotec Limited is a public limited company based in Solan, Himachal Pradesh, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 13 May 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN L24230HP2005PLC028403. Its GSTIN is 02AAACO8296M1Z1 (Himachal Pradesh). It is a listed company as per MCA records. Its shares are listed on NSE: ONYX.

The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹18.13 Cr. It is led by directors including Naresh Kumar (Managing Director) and Harsh Mahajan (Whole-Time Director).

Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Solan, Himachal Pradesh.

As per the latest standalone financials for FY 2025-26, the company reported a revenue of ₹69.47 Cr, a growth of 12.1% compared to the previous year. For the same year it recorded a net loss of ₹21 Lakh (net margin -0.3%) and EBITDA of ₹3.4 Cr (EBITDA margin 4.9%). The net worth stands at ₹55.41 Cr (down 0.4% YoY). Total assets are valued at ₹70.58 Cr (up 3.7% YoY).

The company has about 172 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Onyx Biotec. As per MCA filings, the company has open charges of ₹29.94 Cr and satisfied charges of ₹65.28 Cr on record. Court records list 2 cases involving the company, including 1 filed by the company and 1 filed against it; 1 case is pending. The company has 1 deal on record (1 ipo); the latest was in November 2024. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Sance Laboratories Private Limited with revenue of ₹63.45 Cr. The company has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 46 overdue payments to 5 micro and small suppliers.

Onyx Biotec Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0002709). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website onyxbiotec.com.

Company details

CIN L24230HP2005PLC028403
Registration Number 028403
Incorporation Date 13 May 2005
ROC Himachal Pradesh
Listing Status Listed (NSE: ONYX)
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0002709

CIN history

Onyx Biotec has one previous CIN (Corporate Identification Number): U24230HP2005PTC028403. The current CIN is L24230HP2005PLC028403, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24230HP2005PLC028403Current
U24230HP2005PTC028403Previous
Key People
Naresh Kumar Managing Director Harsh Mahajan Whole-Time Director Parmjeet Kaur Director

Recognitions & Rankings of Onyx Biotec

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-HP-11-0002709

Contact details

Onyx Biotec Limited's registered office is in Solan, Himachal Pradesh. Its website is onyxbiotec.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    onyxbiotec.com
  • Registered Address
    Village Bir Plassi Near Sainimajraropar, Nalagrh Road, Solan, Himachal Pradesh, India – 174101
  • Industry
    Chemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals

To see the full contact details of Onyx Biotec Limited, buy the company report.

Comprehensive company report
Onyx Biotec Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Onyx Biotec operates one associated brand: Onyx Biotec. Each brand links to its own profile.

BrandDescriptionWebsite
Onyx Biotec
Pharmaceutical company that manufactures and distributes generic and proprietary pharmaceutical productsonyxbiotec.com

Business activity

The main business activity of Onyx Biotec is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Onyx Biotec Limited, buy the company report.

Financials of Onyx Biotec Limited

FY 2025-26 filings available

Onyx Biotec Limited reported revenue of ₹69.47 Cr (up 12.1% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Standalone
Revenue
₹69.47 Cr
+12.1% YoY
EBITDA
₹3.40 Cr
-67.2% YoY
Profit After Tax
−₹0.21 Cr
-105.0% YoY
Net Worth
₹55.41 Cr
-0.4% YoY
Total Assets
₹70.58 Cr
+3.7% YoY
Total Debt
₹15.17 Cr
+21.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income statement
Revenue69.4761.9553.7539.4944.86
Revenue growth+12.1%+15.3%+36.1%-12.0%-
EBITDA3.4010.378.404.495.78
EBITDA margin+4.9%+16.7%+15.6%+11.4%+12.9%
Profit before tax(0.42)6.474.502.553.80
Net profit(0.21)4.223.641.863.36
Net profit margin-0.3%+6.8%+6.8%+4.7%+7.5%
EPS (₹)(0.12)2.732.733.135.68
Balance sheet
Total assets70.5868.0856.0747.8729.00
Net worth55.4155.6225.2918.2016.37
Total debt15.1712.4630.7829.2312.25
Cash & bank4.048.611.470.010.01
Net working capital29.2329.1514.215.588.01
Cash flow
Cash from operations(1.49)1.421.521.960.49
Cash from investing(4.58)0.66(3.15)(22.68)(5.78)
Cash from financing1.505.073.0916.435.20

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 11 Nov 2026
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Revenue69.4761.9553.7539.4944.86
Revenue growth+12.1%+15.3%+36.1%-12.0%-
Other income0.441.170.130.120.12
Total expenses66.0751.5845.3535.0039.08
Employee cost0.008.645.9410.488.62
EBITDA3.4010.378.404.495.78
EBITDA margin+4.9%+16.7%+15.6%+11.4%+12.9%
Depreciation3.053.051.871.491.45
Interest1.212.022.160.570.65
Profit before tax(0.42)6.474.502.553.80
Tax(0.21)1.520.860.700.44
Net profit(0.21)4.223.641.863.36
Net profit margin-0.3%+6.8%+6.8%+4.7%+7.5%
EPS (₹)(0.12)2.732.733.135.68
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Equity & liabilities
Share capital18.1318.1313.325.905.90
Reserves & surplus37.2837.4911.9712.3010.47
Shareholders' funds (net worth)55.4155.6225.2918.2016.37
Secured loans14.7111.1928.3126.6311.26
Unsecured loans0.461.272.472.600.99
Total debt15.1712.4630.7829.2312.25
Total liabilities70.5868.0856.0747.8729.00
Assets
Gross block61.8860.5760.1456.9230.33
Net block39.1640.9043.4842.5117.24
Capital work in progress3.680.000.000.004.02
Investments0.000.000.000.000.00
Inventories14.0416.109.106.333.05
Sundry debtors27.5020.2315.375.088.42
Cash & bank balances4.048.611.470.010.01
Loans & advances5.704.243.623.162.95
Total current assets51.2849.1829.5614.5814.43
Total current liabilities22.0520.0315.359.006.42
Net working capital29.2329.1514.215.588.01
Total assets70.5868.0856.0747.8729.00
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Opening cash8.611.470.010.010.11
Net cash from operating activities(1.49)1.421.521.960.49
Net cash from investing activities(4.58)0.66(3.15)(22.68)(5.78)
Net cash from financing activities1.505.073.0916.435.20
Net change in cash(4.57)7.151.46(4.30)(0.09)
Closing cash4.048.611.470.010.01
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Growth
Sales growth+12.1%+15.3%+36.1%-12.0%-
EBITDA growth-67.2%+23.5%+87.1%-22.3%-
PBT growth-+43.8%+76.5%-32.9%+9997.0%
Net income growth-105.0%+15.9%+95.7%-44.6%-
Revenue CAGR (3Y)+20.7%+11.4%---
EBITDA CAGR (3Y)-8.9%+21.5%---
Profitability & leverage
Net income margin-0.3%+8.0%+6.8%+4.7%+7.5%
Return on capital employed-+12.2%+12.8%+8.1%+15.3%
Return on net worth-+10.4%+16.7%+10.7%+20.5%
Debt / equity-0.531.381.200.75
Long-term debt / equity-0.380.960.770.53
Interest cover345.7127.6033.0819.0015.01
Efficiency & per share
Fixed asset turnover-1.230.920.911.48
Inventory turnover-4.926.978.4214.71
Debtors turnover-3.485.265.855.33
EPS (₹)(0.12)2.732.733.135.68
Dividend per share (₹)0.000.000.000.000.00
Book value per share (₹)0.0030.6818.9830.8427.75

To see the full year-wise statements and ratios of Onyx Biotec Limited, buy the company report.

Board of directors of Onyx Biotec Limited

Onyx Biotec has 6 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Naresh KumarManaging Director27 May 200818 Years 5 MonthsCurrent
Harsh MahajanWhole-Time Director01 Nov 20224 Years 0 MonthsCurrent
Parmjeet KaurDirector01 Dec 20196 Years 11 MonthsCurrent
Vineet SinghDirector26 Jul 20242 Years 3 MonthsCurrent
Nitesh Garg
Also directs: Gulshan Polyols Limited, Bridgeline Global Consulting Private Limited
Director26 Jul 20242 Years 3 MonthsCurrent
Prince Preet SinghDirector26 Jul 20242 Years 3 MonthsCurrent
View all directors

Peer comparison

Onyx Biotec Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Onyx Biotec Limitedthis company₹69.47 Cr (FY 2026)-₹21 Lakh-0.3%12.1%172Solan, Himachal Pradesh, India
Sance Laboratories Private Limited₹63.45 Cr (FY 2025)14.0%Kottayam, Kerala, India
Adley Lab Limited₹63.38 Cr (FY 2025)19.0%Derabassi, Punjab, India
Cooper Pharma Limited₹63.28 Cr (FY 2024)-1.0%Delhi, India
Althea Pharma Private Limited₹63.27 Cr (FY 2024)14.0%Vapi, Gujarat, India
Thinq Pharma-Cro Limited₹62.89 Cr (FY 2025)17.0%Mumbai, Maharashtra, India
Preet Remedies Limited₹62.83 Cr (FY 2025)18.0%Chandigarh, India
Sri Gayathri Drugs Private Limited₹62.48 Cr (FY 2025)15.0%Hyderabad, Telangana, India
Shamshree Lifesciences Limited₹62.27 Cr (FY 2025)10.0%Chandigarh, India

To see the full peer comparison of Onyx Biotec Limited, buy the company report.

Auditor

Onyx Biotec Limited is audited by R C A and Co LLP for the financial year 2024.

Auditor firmFinancial yearFirm registration number
R C A and Co LLPFY 2024541484

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 65.10%, foreign institutional investors hold 1.10%, domestic institutional investors hold 2.40% and retail and other public shareholders hold 31.40%.

Promoters: 65.10%DII (Domestic Institutional): 2.40%FII (Foreign Institutional): 1.10%Retail & Others: 31.40%
Sep 2026
QUARTER
65.10% Promoters
2.40% DII (Domestic Institutional)
1.10% FII (Foreign Institutional)
31.40% Retail & Others
Promoter holding - history
Now 65.10% · Sep 2026High 65.10% · Dec 2025Low 65.10% · Dec 2025
64%64.8%65.5%66.3%67%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 65.10%Mar 2026: 65.10%Jun 2026: 65.10%Sep 2026: 65.10%65.10%65.10%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters65.10%65.10%65.10%65.10%
Public34.90%34.90%34.90%34.90%

Charges & borrowings

Open charges
₹29.94 Cr
Satisfied charges
₹65.28 Cr
Breakdown by lending institutions
Hdfc Bank Limited₹29.72 Cr
Others₹0.22 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Aug 2026101373704Hdfc Bank Limited₹22 LakhOpen
17 Feb 2026101241036Others₹22 LakhOpen
21 Jan 2025101046735Hdfc Bank Limited₹29.5 CrOpen
31 Jul 2025101153138Others₹4.5 CrSatisfied
22 Jun 2023100760621Others₹4.05 CrSatisfied

To see the full charge records of Onyx Biotec Limited, buy the company report.

Total charge records: 25 View all charges

Deals & funding

Onyx Biotec Limited has 1 deal on record (1 ipo); the latest was in November 2024.

Total deals
1
IPO
1

Deals on record (1 of 1)

WhenDealAmountParties
Nov 2024IPO₹29.34 CrInvestors: Acintyo Investment Fund, Invicta Continuum Fund, Kingsman Wealth Fund

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME payment delays

Onyx Biotec Limited has 3 MSME Form 1 returns on record for the period ending Sep 2019, listing 46 overdue payments to 5 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 5)

SupplierAmount dueDue sinceReported on
A.R. Industries
an individual supplier
an individual supplier
an individual supplier
Devansh Testing and Research Laboratory Private Limited

To see the full MSME payment records of Onyx Biotec Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Onyx Biotec Limited has a workforce of 172 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
172
Active EPFO establishments
1
Employee growth
-9.9%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-27172
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21
FY 2019-20
FY 2018-19
FY 2017-18
FY 2016-17

To see the full employee and EPFO history of Onyx Biotec Limited, buy the company report.

GST

Onyx Biotec has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
02AAACO8296M1Z1Himachal PradeshActive01 Jul 2017

To see the full GST registrations and return filing status of Onyx Biotec Limited, buy the company report.

Recent activity

Onyx Biotec Limited has 20 board changes on record since 2005: 14 appointments and 6 cessations. The latest: Harsh Jhunjhunwala ceased to be Company Secretary on 22 Jan 2025.

Charges
A charge registered on 07 Mar 2022 via Charge ID 100543674 with Sidbi was fully satisfied on 30 Sep 2026.
Charges
A charge registered on 12 Nov 2021 via Charge ID 100498126 with Sidbi was fully satisfied on 30 Sep 2026.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.22 Cr with Charge ID 101373704 was registered on 24 Aug 2026.
Charges
A charge registered on 27 Jun 2022 via Charge ID 100595890 with Hdfc Bank Limited was fully satisfied on 06 Jul 2026.
Charges
A charge registered on 31 Jul 2025 via Charge ID 101153138 with Others was fully satisfied on 04 Jul 2026.
Charges
A charge with Hdfc Bank Limited of Rs. 29.50 Cr registered on 21 Jan 2025 with Charge ID 101046735 was modified on 07 May 2026.
Filing
Onyx Biotec Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Himachal Pradesh.
Charges
A charge with Others amounted to Rs. 0.22 Cr with Charge ID 101241036 was registered on 17 Feb 2026.
AGM
Onyx Biotec Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Charges
A charge with Others of Rs. 4.50 Cr registered on 31 Jul 2025 with Charge ID 101153138 was modified on 23 Sep 2025.
Charges
A charge registered on 27 Jul 2022 via Charge ID 100603785 with Axis Bank Limited was fully satisfied on 29 Aug 2025.
Charges
A charge with Others amounted to Rs. 4.50 Cr with Charge ID 101153138 was registered on 31 Jul 2025.

64 earlier events are in the company report.

News

Frequently asked questions

Onyx Biotec is an active public limited company based in Solan, Himachal Pradesh, India. The company works in chemical products, within the chemicals industry. It was incorporated on 13 May 2005 (21+ years old) and is registered under CIN L24230HP2005PLC028403. Listed on NSE: ONYX.

Onyx Biotec reported revenue of ₹69.47 Cr for FY 2025-26 (up 12.1% YoY) based on standalone financials.

Onyx Biotec has 6 current directors:

The latest financial statements of Onyx Biotec on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 27 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Onyx Biotec is 02AAACO8296M1Z1, registered in Himachal Pradesh.

The CIN (Corporate Identification Number) of Onyx Biotec is L24230HP2005PLC028403. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. Onyx Biotec is a listed company as per MCA records. Its shares are listed on NSE (symbol: ONYX).

Onyx Biotec has 2 court cases on record: 1 filed by the company and 1 filed against it. 1 is pending.

Onyx Biotec was incorporated on 13 May 2005, making it 21+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

Onyx Biotec has 1 deal on record (1 ipo); the latest was in November 2024.

The peers of Onyx Biotec by revenue are Sance Laboratories Private Limited, Adley Lab Limited, Cooper Pharma Limited, Althea Pharma Private Limited, Thinq Pharma-Cro Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Harsh Jhunjhunwala ceased to be Company Secretary on 22 Jan 2025. Nitesh Garg was appointed as Director on 26 Jul 2024. Prince Preet Singh was appointed as Director on 26 Jul 2024. Onyx Biotec has 20 board changes on record in total.